Hi guys, new to this forum. Been reading and reading and reading for a long time though. Currently I'm on a low dbol cycle, to try my wings more or less. I am planning to jump on my first inject cycle in February next year. I got a few questions though.
I've been reading alot about HCG, can't claim to get any smarter though, fuzzy subject that one. This is how I intend to do the cycle anyway.
w1-20 testo e 250mg e5d
w2-22 HCG
w22-26 Nolvadex 20mg ed (might skip the nolva and jump on the peptide bandwagon instead, depending on what my research leads me to)
My first question is regarding HCG. I'd like to shoot e5d as I will with my testo. Most people seem to hit eod or e3d, is it a must? E5d would be so much more convenient, only one inject interval to keep track off. I was thinking somewhere around 500iu e5d, what do you guys think?
Is there a difference between testo enanthate and testo cypionate? Some say they both got the same half-life, some say cyp got longer.
If someone here is well wandered in the peptide world, mainly regarding GHRP-2 and MOD GRF 1-29, please shoot me a pm, I got a few short questions.
Thanks in advance
Tekton
I've been reading alot about HCG, can't claim to get any smarter though, fuzzy subject that one. This is how I intend to do the cycle anyway.
w1-20 testo e 250mg e5d
w2-22 HCG
w22-26 Nolvadex 20mg ed (might skip the nolva and jump on the peptide bandwagon instead, depending on what my research leads me to)
My first question is regarding HCG. I'd like to shoot e5d as I will with my testo. Most people seem to hit eod or e3d, is it a must? E5d would be so much more convenient, only one inject interval to keep track off. I was thinking somewhere around 500iu e5d, what do you guys think?
Is there a difference between testo enanthate and testo cypionate? Some say they both got the same half-life, some say cyp got longer.
If someone here is well wandered in the peptide world, mainly regarding GHRP-2 and MOD GRF 1-29, please shoot me a pm, I got a few short questions.
Thanks in advance
Tekton
